NHI.no
Annonse
Informasjon

Charcots fot

Charcots fot er en sjelden senkomplikasjon til diabetes type 1 og type 2. Unormale brudd og forskyvninger i leddene er karakteristisk for tilstanden.

Charcots fot finnes i akutt og kronisk tilstand. Ved akutt Charcots fot oppstår symptomer i forbindelse med aktiviteter som belaster foten ekstra, for eksempel uvant lange gåturer. Illustrasjonsfoto: Colourbox.

Sist oppdatert:

19. des. 2023

Dette dokumentet er basert på det profesjonelle dokumentet Diabetesfot, Charcots fot . Referanselisten for dette dokumentet vises nedenfor

  1. Wukich DK, Schaper NC, Gooday C, et al. Guidelines on the diagnosis and treatment of active Charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes Metab Res Rev 2023; 23: e3646. pmid:37218537 PubMed
  2. Tsatsaris G, Ekberg NR, Fall T, Catrina S. Prevalence, incidence and risk factors for Charcot foot in patients with diabetes: a nationwide Swedish study. Abstract. EASD september 2022
  3. Armstrong DG, Todd WF, Lavery LA et al. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997; 14: 357-63. PubMed
  4. Petrova NL, Foster AV, Edmonds ME. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes. Diabet Med 2005; 22: 756-61. PubMed
  5. Jeffcoate WJ. Charcot foot syndrome. Diabet Med 2015; 32: 760-770. pmid:25818542 PubMed
  6. Schaper NC, van Netten JJ, Apelqvist J, et al. Practical guidelines on the prevention and management of diabetes-related foot disease (IWGDF 2023 update). Diabetes Metab Res Rev 2023; 27: e3657. pmid:37243927 PubMed
  7. Jones KB, Maiers Yelden KA, Marsh JL et al. Ankle fractures in patients with diabetes mellitus. J Bone Joint Surg Br 2005; 87: 489-95. PubMed
  8. Holstein P, Lohmann M, Bitsch M et al. Achilles tendon lengthening, the panacea for plantar forefoot ulceration? Diabetes Metab Res Rev 2004; 20: 37-40. PubMed
  9. Wukich DK, Sung W, Wipf SA, Grimaldi A. The consequences of complatency: managing the effects of unrecognized Charcot feet. Diabet Med 2011; 28: 195-8. PubMed
  10. Crawford F, Cezard G, Chappell FM, et al. A systematic review and individual patient data meta-analysis of prognostic factors for foot ulceration in people with diabetes: the international research collaboration for the prediction of diabetic foot ulcerations (PODUS). Health Technology Assessment, No. 19.57. 2015. legehandboka.no
  11. Helsedirektoratet. Nasjonal faglig retningslinje for diabetes. Oslo; Helsedirektoratet 2019. helsedirektoratet.no
  12. Pinzur MS, Lio T, Posner M. Treatment of Eichenholtz stage I Charcot foot arthropathy with a weightbearing total contact cast. Foot Ankle Int 2006; 27: 324-9. PubMed
  13. Christensen TM, Yderstræde K, Ejskjær N, et al. Den diabetiske Charcots fod. Ugeskr Læger 2008; 170: 2440. PubMed
  14. Ramanujam CL, Stuto AC, Zgonis T. Surgical treatment of midfoot Charcot neuroarthropathy with osteomyelitis in patients with diabetes: a systematic review. J Wound Care 2020; 29: 19-28. pmid:32530758 PubMed
  15. Fabrin J, Larsen K, and Holstein PE. Arthrodesis with external fixation in the unstable or misaligned Charcot ankle in patients with diabetes mellitus. Int J Low Extrem Wounds 2007; 6: 102-7. PubMed
  16. Hastings MK, Sinacore DR, Fielder FA et al. Bone mineral density during total contact cast immobilization for a patient with neuropathic (Charcot) arthropathy. Phys Ther 2005; 85: 249-56. PubMed
Annonse
Annonse